A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.

Saved in:

Bibliographic Details
Title:	A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of Electroporated HIV DNA with or without Interleukin 12 in Prime-Boost Combinations with an Ad35 HIV Vaccine in Healthy HIV-Seronegative African Adults.
Authors:	Mpendo J; Uganda Virus Research Institute-IAVI, Entebbe, Uganda., Mutua G; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Nyombayire J; Projet San Francisco (PSF), Kigali, Rwanda., Ingabire R; Projet San Francisco (PSF), Kigali, Rwanda., Nanvubya A; Uganda Virus Research Institute-IAVI, Entebbe, Uganda., Anzala O; Kenya AIDS Vaccine Initiative, University of Nairobi, Nairobi, Kenya., Karita E; Projet San Francisco (PSF), Kigali, Rwanda., Hayes P; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom., Kopycinski J; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom., Dally L; EMMES Corporation, Rockville, Maryland, United States of America., Hannaman D; ICHOR Medical Systems, Inc., San Diego, California, United States of America., Egan MA; Profectus BioSciences, Inc., Tarrytown, New York, United States of America., Eldridge JH; Profectus BioSciences, Inc., Tarrytown, New York, United States of America., Syvertsen K; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Lehrman J; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Rasmussen B; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Gilmour J; IAVI, Human Immunology Laboratory, Imperial College, London, United Kingdom., Cox JH; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Fast PE; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America., Schmidt C; International AIDS Vaccine Initiative (IAVI), New York, New York, United States of America.
Source:	PloS one [PLoS One] 2015 Aug 07; Vol. 10 (8), pp. e0134287. Date of Electronic Publication: 2015 Aug 07 (Print Publication: 2015).
Publication Type:	Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info:	Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	1932-6203
DOI:	10.1371/journal.pone.0134287